Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 84

    1.

    Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users.

    Grau LE, Green TC, Singer M, Bluthenthal RN, Marshall PA, Heimer R.

    Harm Reduct J. 2009 Dec 15;6:36.

    PMID:
    20003518
    [PubMed]
    Free PMC Article
    2.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    3.

    Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities.

    Heimer R, Clair S, Grau LE, Bluthenthal RN, Marshall PA, Singer M.

    Addiction. 2002 Oct;97(10):1277-87.

    PMID:
    12359032
    [PubMed - indexed for MEDLINE]
    4.

    Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.

    Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH.

    Addiction. 2007 Apr;102(4):638-46. Epub 2007 Feb 6.

    PMID:
    17286637
    [PubMed - indexed for MEDLINE]
    5.

    Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.

    Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, Malow R, McClellan WM.

    Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. Review.

    PMID:
    18646068
    [PubMed - indexed for MEDLINE]
    6.

    HIV infection among intravenous drug users: epidemiology and risk reduction.

    Des Jarlais DC, Friedman SR.

    AIDS. 1987 Jul;1(2):67-76. Review.

    PMID:
    3130084
    [PubMed - indexed for MEDLINE]
    7.

    A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.

    Finlinson HA, Oliver-Vélez D, Deren S, Cant JG, Colón HM, Robles RR, Kang SY, Andía JF.

    Subst Use Misuse. 2006;41(9):1313-36.

    PMID:
    16861181
    [PubMed - indexed for MEDLINE]
    8.

    Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.

    Bluthenthal RN, Kral AH, Erringer EA, Edlin BR.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):505-11.

    PMID:
    9715848
    [PubMed - indexed for MEDLINE]
    9.

    The impact of legalizing syringe exchange programs on arrests among injection drug users in California.

    Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn N, Kral AH.

    J Urban Health. 2007 May;84(3):423-35.

    PMID:
    17265133
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    11.

    Impact of a longitudinal community HIV intervention targeting injecting drug users' stage of change for condom and bleach use.

    Jamner MS, Wolitski RJ, Corby NH.

    Am J Health Promot. 1997 Sep-Oct;12(1):15-24.

    PMID:
    10170430
    [PubMed - indexed for MEDLINE]
    12.

    Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies.

    Kral AH, Anderson R, Flynn NM, Bluthenthal RN.

    J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1307-12.

    PMID:
    15385739
    [PubMed - indexed for MEDLINE]
    13.

    Maintaining technical quality of care in the introduction of Cyclofem in a national family planning program: findings from Indonesia.

    Lubis F, Fajans P, Simmons R.

    Contraception. 1994 May;49(5):527-41.

    PMID:
    8045136
    [PubMed - indexed for MEDLINE]
    14.

    Outreach-based HIV prevention for injecting drug users: a review of published outcome data.

    Coyle SL, Needle RH, Normand J.

    Public Health Rep. 1998 Jun;113 Suppl 1:19-30. Review.

    PMID:
    9722807
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Secondary syringe exchange among users of 23 California syringe exchange programs.

    Lorvick J, Bluthenthal RN, Scott A, Gilbert ML, Riehman KS, Anderson RL, Flynn NM, Kral AH.

    Subst Use Misuse. 2006;41(6-7):865-82.

    PMID:
    16809176
    [PubMed - indexed for MEDLINE]
    16.

    Risk contexts and risk behaviors in the Euregion Maas-Rhein: the Boule de Neige intervention for AIDS prevention among drug users.

    Franken IH, Kaplan CD.

    AIDS Educ Prev. 1997 Apr;9(2):161-80.

    PMID:
    9167801
    [PubMed - indexed for MEDLINE]
    17.

    Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

    Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC.

    Harm Reduct J. 2009 Feb 20;6:3.

    PMID:
    19232088
    [PubMed]
    Free PMC Article
    18.

    The role of needle exchange programs in HIV prevention.

    Vlahov D, Junge B.

    Public Health Rep. 1998 Jun;113 Suppl 1:75-80. Review.

    PMID:
    9722812
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Psychoeducational group approach: HIV risk reduction in drug users.

    Sorensen JL, London J, Heitzmann C, Gibson DR, Morales ES, Dumontet R, Acree M.

    AIDS Educ Prev. 1994 Apr;6(2):95-112.

    PMID:
    8018443
    [PubMed - indexed for MEDLINE]
    20.

    Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs.

    Grau LE, Bluthenthal RN, Marshall P, Singer M, Heimer R.

    AIDS Behav. 2005 Dec;9(4):495-504.

    PMID:
    16237501
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk